

Scotland-based Pneumagen, which focuses on treating infectious diseases by targeting the human glycome, has raised 4 million pounds in funding. Thairm Bio led the round with participation from the Scottish Investment Bank.
Source: Press Release
Scotland-based Pneumagen, which focuses on treating infectious diseases by targeting the human glycome, has raised 4 million pounds in funding.
Scotland-based Pneumagen, which focuses on treating infectious diseases by targeting the human glycome, has raised 4 million pounds in funding. Thairm Bio led the round with participation from the Scottish Investment Bank.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination